Rabinder Kumar Prinjha

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rabinder Kumar Prinjha. Retrieved from https://idiyas.com/inventor/rabinder-kumar-prinjha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.8

ph-index = 1

Company Filing History:

Smithkline Beecham Corporation

patents

where one patent can have more than one assignee

Years Active: 2007-2013

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8362208 - Immunoglobulins (2013-01-29),

2. 7988964 - NOGO-a neutralising immunoglobulin for treatment of neurological diseases (2011-08-02),

3. 7270962 - Method of identifying modulators of nogo-functions (2007-09-18),

Title: Rabinder Kumar Prinjha: Pioneering Innovations in Neurological Treatments

Introduction

Rabinder Kumar Prinjha is a notable inventor based in Harlow, GB, recognized for his significant contributions in the field of immunology. With a portfolio of three patents, he has developed innovative solutions aimed at treating neurological diseases.

Latest Patents

His most recent patents focus on immunoglobulins, specifically antibodies that target NOGO. The patents detail pharmaceutical formulations containing these antibodies and their use in the treatment and prophylaxis of neurological disorders. The two key patents include one that relates to antibodies to NOGO and another which provides neutralizing immunoglobulins for treating neurological diseases. These inventions highlight his commitment to advancing treatments for complex health conditions.

Career Highlights

Throughout his career, Rabinder Kumar Prinjha has contributed to major pharmaceutical companies including Glaxo Group Limited and SmithKline Beecham Corporation. His work in these organizations has been instrumental in developing therapies that address pressing medical challenges.

Collaborations

In addition to his individual accomplishments, Prinjha has collaborated with notable colleagues such as Jonathan Henry Ellis and Ruth McAdam. These partnerships have likely fostered innovative ideas and facilitated the development of groundbreaking therapies in immunology and neurology.

Conclusion

Rabinder Kumar Prinjha's dedication to scientific research and innovation in the field of immunology marks him as an influential figure in the pursuit of effective treatments for neurological diseases. His patents and collaborative efforts contribute significantly to advancing healthcare solutions worldwide.

Profile summary based on public USPTO records.